FDA Says Industry Has Work Left To Do To Make Antiviral Claims For Topicals
This article was originally published in The Tan Sheet
Executive Summary
FDA rejects a citizen petition seeking antiviral labeling for OTC products covered by the Healthcare Antiseptic Drug Products monograph
You may also be interested in...
Industry Groups Need FDA Input On Antibacterial Ingredient Studies
The Personal Care Products Council and American Cleaning Institute say industry needs FDA input on study designs and more time to study benzethonium and benzalkonium chloride in consumer antimicrobial wash products. FDA’s commitment under a 2013 consent decree to publish a monograph for triclosan use by September 2016 should not influence the GRASE status of other ingredients, the groups say.
Industry Groups Need FDA Input On Antibacterial Ingredient Studies
The Personal Care Products Council and American Cleaning Institute say industry needs FDA input on study designs and more time to study benzethonium and benzalkonium chloride in consumer antimicrobial wash products. FDA’s commitment under a 2013 consent decree to publish a monograph for triclosan use by September 2016 should not influence the GRASE status of other ingredients, the groups say.
Hand Sanitizers Limited To Sterile Claims But Cleaning Up Amid Flu Worries
Consumer fears stemming from a second wave of 2009-H1N1 flu virus cases are helping drive sales of hand sanitizers, but marketers must tread lightly when it comes to associating their products with protection against viruses